Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
perhexiline
Description:
A chemical compound used as an antianginal drug that alters cardiac energy metabolism by inhibiting fatty-acid oxidation.
Related topics:
Pharmacogenetics and Drug Metabolism (11%),
Cardiac electrophysiology and arrhythmias (7%)
Wikidata ID:
wiki/Q1232737
OpenAlex ID:
keywords/perhexiline
Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity
1995
·
Bernard Fromenty
, Dominique Pessayre
·
Pharmacology & Therapeutics
·
742
Pharmacogenetics, Drug-Metabolizing Enzymes, and Clinical Practice
2006
·
Sharon J. Gardiner
, Evan J. Begg
·
Pharmacological Reviews
·
464
Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes
1998
·
Alain Berson
, Virginie De Beco
, et al.
·
Gastroenterology
·
435
PDF
Metabolic Modulation With Perhexiline in Chronic Heart Failure: A Randomized, Controlled Trial of Short-Term Use of a Novel Treatment
2005
·
Leong Lee
, Ross Campbell
, et al.
·
Circulation
·
384
Screen for Chemical Modulators of Autophagy Reveals Novel Therapeutic Inhibitors of mTORC1 Signaling
2009
·
Aruna D. Balgi
, Bruno D. Fonseca
, et al.
·
PLoS ONE
·
373
PDF
Metabolic Modulator Perhexiline Corrects Energy Deficiency and Improves Exercise Capacity in Symptomatic Hypertrophic Cardiomyopathy
2010
·
Khalid Abozguia
, Perry Elliott
, et al.
·
Circulation
·
340
Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Part I: Basic and Clinical Electrophysiologic Effects
1980
·
ELLIOTT M. ANTMAN
, PETER H. STONE
, et al.
·
Annals of Internal Medicine
·
337
Modulating fatty acid oxidation in heart failure
2011
·
V. Lionetti
, W. C. Stanley
, et al.
·
Cardiovascular Research
·
265
PDF
Drugs and Steatohepatitis
2002
·
Geoffrey Farrell
·
Seminars in Liver Disease
·
250
Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone
1996
·
Jennifer A. Kennedy
, Steven A. Unger
, et al.
·
Biochemical Pharmacology
·
229
Impaired oxidation of debrisoquine in patients with perhexiline neuropathy.
1982
·
R R Shah
, N S Oates
, et al.
·
BMJ
·
218
PDF
Perhexiline
2007
·
Houman Ashrafian
, John D. Horowitz
, et al.
·
Cardiovascular Drug Reviews
·
196
Can Pharmacogenetics Help Rescue Drugs Withdrawn from the Market?
2006
·
Rashmi R Shah
·
Pharmacogenomics
·
193
Metabolic manipulation in ischaemic heart disease, a novel approach to treatment
2004
·
L Lee
, John Horowitz
, et al.
·
European Heart Journal
·
192
Amiodarone and its desethyl metabolite: tissue distribution and morphologic changes during long-term therapy.
1985
·
P C Adams
, D W Holt
, et al.
·
Circulation
·
184
The Adrenergic-Fatty Acid Load in Heart Failure
2009
·
Lionel H. Opie
, Juhani Knuuti
·
Journal of the American College of Cardiology
·
167
PDF
Impaired oxidation of debrisoquine in patients with perhexiline liver injury.
1984
·
M Y Morgan
, R Reshef
, et al.
·
Gut
·
163
PDF
Oleate prevents palmitate-induced cytotoxic stress in cardiac myocytes
2005
·
Thomas A. Miller
, Nathan K. LeBrasseur
, et al.
·
Biochemical and Biophysical Research Communications
·
161
Factors influencing the long-term prognosis of treated patients with variant angina.
1983
·
D D Waters
, D D Miller
, et al.
·
Circulation
·
156
PDF
Low STAT3 expression sensitizes to toxic effects of β-adrenergic receptor stimulation in peripartum cardiomyopathy
2016
·
Britta Stapel
, Michael Kohlhaas
, et al.
·
European Heart Journal
·
153
PDF
Carnitine palmitoyltransferase gene upregulation by linoleic acid induces CD4+ T cell apoptosis promoting HCC development
2018
·
Zachary J. Brown
, Qiong Fu
, et al.
·
Cell Death and Disease
·
152
PDF
Drug Binding to the Inactivated State Is Necessary but Not Sufficient for High-Affinity Binding to Human Ether-à-go-go-Related Gene Channels
2008
·
Mark J. Perrin
, Philip W. Kuchel
, et al.
·
Molecular Pharmacology
·
147
Searching for New Antimalarial Therapeutics amongst Known Drugs
2006
·
Jennifer L. Weisman
, Ally P. Liou
, et al.
·
Chemical Biology & Drug Design
·
136
Drug-induced fatty liver disease: An overview of pathogenesis and management
2015
·
Sanjaya K. Satapathy
, Vanessa Kuwajima
, et al.
·
Annals of Hepatology
·
131
PDF
Improvement in Cardiac Energetics by Perhexiline in Heart Failure Due to Dilated Cardiomyopathy
2015
·
Roger M. Beadle
, Lynne K. Williams
, et al.
·
JACC Heart Failure
·
128
PDF
Show more works
View as search
Works count:
525
Citation count:
14,330
Year
Topic
Type